Abstract
The rapid diffusion of carbapenem-resistant (C-R) Klebsiella pneumoniae (Kp) represents a global concern from both clinical and public health standpoints. In particular, bloodstream infections sustained by C-R Kp are associated with high mortality rates and the treatment of these clinical picture is a major challenge for clinicians.
Highlights
The rapid diffusion of carbapenem-resistant (C-R) Klebsiella pneumoniae (Kp) represents a global concern from both clinical and public health standpoints
The annual incidence of C-S Kp BSI remained steady throughout the study period. 30-day survival was significantly lower in C-R patients than C-S patients (Logrank p = 0.002)
In our hospital we observed a dramatic increase in the incidence of C-R Kp BSI occurred from 2009 to 2014
Summary
The rapid diffusion of carbapenem-resistant (C-R) Klebsiella pneumoniae (Kp) represents a global concern from both clinical and public health standpoints. From 3rd International Conference on Prevention and Infection Control (ICPIC 2015) Geneva, Switzerland. Introduction The rapid diffusion of carbapenem-resistant (C-R) Klebsiella pneumoniae (Kp) represents a global concern from both clinical and public health standpoints. Bloodstream infections sustained by C-R Kp are associated with high mortality rates and the treatment of these clinical picture is a major challenge for clinicians.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.